Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry

医学 儿科 抗磷脂综合征 血栓形成 外科
作者
Jaume Alijotas‐Reig,Enrique Esteve‐Valverde,Raquel Ferrer‐Oliveras,Luis Saez Comet,Eleftheria Elmina Lefkou,Arsène MEKINIAN,Cristina C. Belizna,Amelia Ruffatti,Ariela Hoxha,Anǵela Tincani,Cecilia Nalli,Luca Marozio,Aldo Maina,Gerard Espinosa,Roberto Ríos Garcés,Ricard Cervera,Sara De Carolis,Giuseppina Monteleone,Omar Latino,Sebastián Udry
出处
期刊:Rheumatology [Oxford University Press]
卷期号:59 (6): 1306-1314 被引量:99
标识
DOI:10.1093/rheumatology/kez419
摘要

OBJECTIVES: To compare clinical features, laboratory data and fetal-maternal outcomes between 1000 women with obstetric APS (OAPS) and 640 with aPL-related obstetric complications not fulfilling Sydney criteria (non-criteria OAPS, NC-OAPS). METHODS: This was a retrospective and prospective multicentre study from the European Registry on Obstetric Antiphospholipid Syndrome. RESULTS: A total of 1650 women with 5251 episodes, 3601 of which were historical and 1650 latest episodes, were included. Altogether, 1000 cases (OAPS group) fulfilled the Sydney classification criteria and 650 (NC-OAPS group) did not. Ten NC-OAPS cases were excluded for presenting thrombosis during follow-up. All cases were classified as category I (triple positivity or double positivity for aPL) or category II (simple positivity). Overall, aPL laboratory categories showed significant differences: 29.20% in OAPS vs 17.96% in NC-OAPS (P < 0.0001) for category I, and 70.8% in OAPS vs 82% in NC-OAPS (P < 0.0001) for category II. Significant differences were observed when current obstetric complications were compared (P < 0.001). However, major differences between groups were not observed in treatment rates, livebirths and thrombotic complications. In the NC-OAPS group, 176/640 (27.5%) did not fulfil Sydney clinical criteria (subgroup A), 175/640 (27.34%) had a low titre and/or non-persistent aPL positivity but did meet the clinical criteria (subgroup B) and 289/640 (45.15%) had a high aPL titre but did not fulfil Sydney clinical criteria (subgroup C). CONCLUSION: Significant clinical and laboratory differences were found between groups. Fetal-maternal outcomes were similar in both groups when treated. These results suggest that we could improve our clinical practice with better understanding of NC-OAPS patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
gqzhu完成签到,获得积分10
2秒前
2秒前
abw发布了新的文献求助10
4秒前
5秒前
5秒前
5秒前
ding的应助被欢喜夏兰采纳,获得10
5秒前
小二郎的应助被369ninja采纳,获得10
6秒前
碧蓝的晓曼关注了科研通微信公众号
6秒前
浮云发布了新的文献求助30
6秒前
zz完成签到,获得积分10
6秒前
畅快紫菱发布了新的文献求助10
7秒前
云岫完成签到,获得积分10
7秒前
余香的应助被明亮的迎松采纳,获得10
7秒前
8秒前
8秒前
null的应助被Rice采纳,获得10
9秒前
火焰迷踪发布了新的文献求助10
9秒前
维维发布了新的文献求助10
10秒前
深情安青的应助被gwc567采纳,获得10
11秒前
樱桃小丸犊子完成签到 ,获得积分10
11秒前
涵涵涵涵完成签到 ,获得积分10
11秒前
11秒前
12秒前
听雪冬眠发布了新的文献求助10
12秒前
12秒前
qin202569发布了新的文献求助10
12秒前
u216593完成签到,获得积分10
13秒前
一颗苹果的应助被科研通管家采纳,获得10
13秒前
丘比特的应助被科研通管家采纳,获得10
13秒前
13秒前
orixero的应助被科研通管家采纳,获得10
13秒前
传奇3的应助被JIANGNANYAN采纳,获得10
14秒前
一颗苹果的应助被科研通管家采纳,获得10
14秒前
楚轩之圣的应助被科研通管家采纳,获得10
14秒前
风吹麦浪的应助被科研通管家采纳,获得10
14秒前
领导范儿的应助被科研通管家采纳,获得10
14秒前
一颗苹果的应助被科研通管家采纳,获得10
14秒前
一颗苹果的应助被科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962